Analytical and inter-observer comparability of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry assays in advanced clear cell renal cell carcinoma (CCRCC)

Sommer U, Eckstein M, Ammann J, Braunschweig T, Macher-Goeppinger S, Schwamborn K, Hieke-Schulz S, Wullich B, Wirth M, Roth W, Knuechel R, Weichert W, Baretton G, Hartmann A (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Cancer Research American Association for Cancer Research

Publisher: AMER ASSOC CANCER RESEARCH

City/Town: PHILADELPHIA

Conference Proceedings Title: CANCER RESEARCH

Event location: Atlanta, GA

DOI: 10.1158/1538-7445.AM2019-4037

Authors with CRIS profile

Markus Eckstein Institute of Pathology Bernd Wullich Lehrstuhl für Urologie Arndt Hartmann Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Involved external institutions

Roche Deutschland Holding GmbH DE Germany (DE) Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen DE Germany (DE) Technische Universität München (TUM) DE Germany (DE) Universitätsmedizin der Johannes Gutenberg-Universität Mainz DE Germany (DE) Technische Universität Dresden DE Germany (DE)

How to cite

APA:

Sommer, U., Eckstein, M., Ammann, J., Braunschweig, T., Macher-Goeppinger, S., Schwamborn, K.,... Hartmann, A. (2019). Analytical and inter-observer comparability of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry assays in advanced clear cell renal cell carcinoma (CCRCC). In CANCER RESEARCH. Atlanta, GA: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

MLA:

Sommer, Ulrich, et al. "Analytical and inter-observer comparability of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry assays in advanced clear cell renal cell carcinoma (CCRCC)." Proceedings of the Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta, GA PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2019.

BibTeX: Download